Literature DB >> 21115955

Association of reversed Robin Hood syndrome with risk of stroke recurrence.

P Palazzo1, C Balucani, K Barlinn, G Tsivgoulis, Y Zhang, L Zhao, J Dewolfe, B Toaldo, E Stamboulis, F Vernieri, P M Rossini, A V Alexandrov.   

Abstract

BACKGROUND: Reversed Robin Hood syndrome (RRHS) has recently been identified as one of the mechanisms of early neurologic deterioration in acute ischemic stroke (AIS) patients related to arterial blood flow steal from ischemic to nonaffected brain. We sought to investigate the association of RRHS with risk of stroke recurrence in a single-center cohort study.
METHODS: Consecutive patients with AIS or TIA affecting the anterior circulation were prospectively evaluated with serial NIH Stroke Scale assessments and bilateral transcranial Doppler monitoring with breath-holding test. RRHS was defined according to previously validated criteria.
RESULTS: A total of 360 patients (51% women, mean age 62 ± 15 years) had an ischemic stroke (81%) or TIA (19%) in the anterior circulation, and 30 (8%) of them had RRHS. During a mean follow-up period of 6 months (range 1-24), a total of 16 (4%) recurrent strokes (15 ischemic and 1 hemorrhagic) were documented. The cumulative recurrence rate was higher in patients with RRHS (19%; 95% confidence interval [CI] 1-37) compared to the rest (15%; 95% CI 0-30; p = 0.022 by log-rank test). All recurrent strokes in patients with RRHS were cerebral infarcts that occurred in the ipsilateral to the index event anterior circulation vascular territory. After adjusting for demographic characteristics, vascular risk factors, and secondary prevention therapies, RRHS was independently associated with a higher stroke recurrence risk (hazard ratio 7.31; 95% CI 2.12-25.22; p = 0.002).
CONCLUSIONS: Patients with AIS and RRHS appear to have a higher risk of recurrent strokes that are of ischemic origin and occur in the same arterial territory distribution to the index event. Further independent validation of this association is required in a multicenter setting.

Entities:  

Mesh:

Year:  2010        PMID: 21115955     DOI: 10.1212/WNL.0b013e3181ffe4e4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  Adjunctive and alternative approaches to current reperfusion therapy.

Authors:  Andrew D Barreto; Andrei V Alexandrov
Journal:  Stroke       Date:  2012-01-05       Impact factor: 7.914

2.  Association of sleep apnea with clinically silent microvascular brain tissue changes in acute cerebral ischemia.

Authors:  Jessica Kepplinger; Kristian Barlinn; Amelia K Boehme; Johannes Gerber; Volker Puetz; Lars-Peder Pallesen; Wiebke Schrempf; Imanuel Dzialowski; Karen C Albright; Andrei V Alexandrov; Heinz Reichmann; Ruediger von Kummer; Ulf Bodechtel
Journal:  J Neurol       Date:  2013-11-30       Impact factor: 4.849

3.  Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis.

Authors:  Mauro Silvestrini; Claudia Altamura; Raffaella Cerqua; Patrizio Pasqualetti; Giovanna Viticchi; Leandro Provinciali; Luca Paulon; Fabrizio Vernieri
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-30       Impact factor: 6.200

4.  Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease.

Authors:  Paola Palazzo; Paola Maggio; Riccardo Altavilla; Alessandra Di Flaviani; Ilaria Giordani; Ilaria Malandrucco; Fabiana Picconi; Francesco Passarelli; Patrizio Pasqualetti; Matilde Ercolani; Fabrizio Vernieri; Simona Frontoni
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Cerebral ambiguity.

Authors:  Claudio Baracchini
Journal:  Brain Behav       Date:  2014-09       Impact factor: 2.708

6.  Reversal of the neurological deficit in acute stroke with the signal of efficacy trial of auto-BPAP to limit damage from suspected sleep apnea (Reverse-STEAL): study protocol for a randomized controlled trial.

Authors:  Jessica Kepplinger; Kristian Barlinn; Stanislava Kolieskova; Reza Bavarsad Shahripour; Lars-Peder Pallesen; Wiebke Schrempf; Xina Graehlert; Uta Schwanebeck; April Sisson; Charlotte Zerna; Volker Puetz; Heinz Reichmann; Karen C Albright; Anne W Alexandrov; Milan Vosko; Robert Mikulik; Ulf Bodechtel; Andrei V Alexandrov
Journal:  Trials       Date:  2013-08-13       Impact factor: 2.279

7.  Cerebrovascular consequences of obstructive sleep apnea.

Authors:  David J Durgan; Robert M Bryan
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.